Vestas Wind Systems reported a smaller than expected increase in Q2 operating profit while maintaining its full-year guidance ...

Vor Bio's partner, RemeGen, achieves late-stage trial success for telitacicept in Sjögren's disease. Read more here.

Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating ...

Hudbay Minerals (NYSE:HBM) +13.2% pre-market Wednesday after posting better than expected Q2 adjusted earnings and announcing ...

London (UKX) +0.27% to 9,171. Germany (DAX:IND) +0.60% to 24,168. Germany's inflation steady at eight-month low France (CAC:IND) +0.26% to 7,771. Spain's inflation rises to 2.7% in July Paraguay ...